News

CDMO’s Ireland campus will increase in capacity by 50% as a result

Expanded partnership revolves around hemophilia A therapeutics

Configurable applications address patient and healthcare-provider interfaces, and an analytics dashboard

Will serve as a hub, as company aims for growth in the European region

GMP facility allows for an increase in AAV vector production

Dominance of a handful of integrated firms “at the center of the US pharmaceutical system,” plus their trade practices, will be reviewed

Transaction totals about $3 billion

Project is expected to grow CRDO’s capacity by over 150,000 square feet

Platform delivers intelligent digital twins specifically designed for real-time supply chain operations across the extended enterprise

Deal expands CDMO’s presence in Europe

The latest people news happenings over the past month

Goal of ‘Closer to the Formulator’ is to offer a more efficient pharma production process

As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses

Investment will grow manufacturing capabilities at Winchester site

East Syracuse site will serve as a hub for company’s US biologics CDMO business

Should be administered at least five months after the second dose of the two-dose primary series

Deal establishes company’s presence in Mexico

It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate, and scale APT supply chains with one single system, the company reports

Will be investing up to $100 million to expand presence in Taiwan

Company anticipating to double global network size by end of the year

Among functions, 80,000 square-foot space will house a 'Center of Excellence'

Location will feature aseptic fill-finish technology

Deal for PROPENSITY4 grows company’s data analytics knowledge

Pfizer to commercialize NURTEC® ODT, an innovative compound for the prevention and acute treatment of migraine

Per supply chain agreement, CDMO will provide analytical product support

Among efforts, part of center’s focus revolves providing tools for product commercialization

New partnership focused on improving quality of care, patient outcomes and safety in health systems

Facility will feature biologic manufacturing, along with late-stage research and clinical development of cancer medicines